Polgarova K - Dept Biocev, Charles Univ Prague

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 27 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

PCNSL Patients Treated with the Matrix Regimen in the Real World Have Similar Outcome to Those in the IELSG 32 Trial

Prokop Vodicka,Katerina Benesova,Andrea Janikova, David Belada,Veronika Hanackova,Heidi Mocikova, Juraj Duras,Katerina Steinerova,Eva Konirova,Tomas Prochazka,Kamila Polgarova,Jitka Dlouha, Petra Blahovcova,Marek Trneny

Bloodno. Supplement 1 (2024): 1711-1711

引用0浏览0引用

Several Factors That Predict the Outcome of Large B-cell Lymphoma Patients Who Relapse/progress after Chimeric Antigen Receptor (CAR) T-cell Therapy Can Be Identified Before Cell Administration

Alice Sykorova,Frantisek Folber,Kamila Polgarova,Heidi Mocikova,Juraj Duras,Katerina Steinerova,Ales Obr,Adriana Heindorfer,Miriam Ladicka, Lubica Lukacova, Erika Cellarova,Ivana Plamenova,David Belada,Andrea Janikova,Marek Trneny, Tereza Jancarkova,Vit Prochazka,Andrej Vranovsky, Margareta Kralikova,Jan Vydra,Lukas Smolej,Lubos Drgona, Martin Sedmina,Eva Cermakova,Robert Pytlik

CANCER MEDICINEno. 17 (2024)

引用0浏览0WOS引用

An Evaluation of Glofitamab, the First Fixed-Duration Bispecific Antibody for Relapsed or Refractory Large B-cell Lymphomas

Kamila Polgarova,Marek Trneny

Expert Opinion on Biological Therapy（2024）

引用0浏览0WOS引用

Circulating Tumor DNA As a Predictor of Survival of DLBCL Patients in a Daily Practice

Iva Hamova,Prokop Vodicka, Adriana Velasova,Kristyna Kupcova,Petra Zemankova, Petr Nehasil, Anton Tkachenko,Kamila Polgarova, Jana Salkova,Katerina Benesova, Pavel Klener,Marek Trneny, Ondrej Havranek

Bloodno. Supplement 1 (2024): 6235-6235

引用0浏览0引用

Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still Be Considered the Standard of Care

Liliana Tuskova,Diana Maláriková,Katerina Benesova,Eva Konirova,Kamila Polgarova, Petra Blahovcova, Jana Salkova,Marek Trněný, Pavel Klener

Bloodno. Supplement 1 (2024): 3012-3012

引用0浏览0引用

CAR T-lymphocytes in the Treatment of Non-Hodkgin's Lymphoma: Current Perspectives

Kamila Polgárová

Onkologie（2024）

引用0浏览0引用

BMI and Its Changes As a Predictor of Survival in DLBCL Patients

Michal Masar,Prokop Vodicka,Magdalena Klanova,Kamila Polgarova,Katerina Benesova,Diana Malarikova, Jana Salkova,Jan Koren, Pavel Klener,Marek Trneny

Bloodno. Supplement 1 (2024): 1713-1713

引用0浏览0引用

Characterization of the Input Material Quality for the Production of Tisagenlecleucel by Multiparameter Flow Cytometry and Its Relation to the Clinical Outcome

Martin Stach,Robert Pytlik,Kristyna Smilauerova, Jana Rychla,Martin Mucha,Jan Musil,Abhishek Koladiya, Matej Nemec,Martina Petrackova,Iva Kastankova,Pavla Pecherkova,Lucie Sramkova,Kamila Polgarova,Marek Trneny,Petr Lesny,Jan Vydra,Pavel Otahal

PATHOLOGY & ONCOLOGY RESEARCH（2023）

引用0浏览0WOS引用

OUTCOMES OF THE TREATMENT AFTER ANTI‐CD19 CAR‐T THERAPY FAILURE IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA—ANALYSIS OF DATA FROM THE CZECH REPUBLIC

A. Sýkorová,K. Polgárová,F. Folber,J. Ďuraš,H. Móciková,K. Steinerová,A. Obr,D. Belada,L. Smolej,M. Trněný,R. Pytlík

Hematological Oncologyno. S2 (2023): 792-793

引用0浏览0引用

Chimeric Antigen Receptor Based Cellular Therapy for Treatment of T-Cell Malignancies

Kamila Polgárová,Pavel Otáhal,Cyril Šálek,Robert Pytlík

Frontiers in oncology（2022）

引用9浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn